A recent study found that semaglutide, a GLP-1 weight loss drug, reduced knee pain in people with obesity and knee osteoarthritis. Experts say the reduced knee pain actually comes from weight loss, ...

GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...

Powers Health surgical and medical weight-loss services in Hobart and Munster provide tailored support and experts who ...

In one hand, a slender young woman holds up a bottle of clear liquid. The words “Skinny” and “GLP-1” — a new class of weight loss drugs — are visible on the label. In the other hand, she raises up a ...

The analysis used health data from the Rochester Epidemiology Project collected from 2000 to 2022. The first GLP-1 medication was prescribed beginning in 2006, and the authors included cases beginning ...

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...

A s doctors and researchers learn more about Ozempic's health benefits, many are impressed. Besides lowering blood sugar in ...

Drugs that belong to the class of GLP-1 receptor agonists could cause muscle loss These drugs reduce appetite and are used ...

Stroke survivors can significantly lower their risk of another stroke, a heart attack or premature death by taking a diabetes drug like Ozempic or Jardiance, new preliminary research finds.

She claims the solution she was 'gifted' to lose weight was claimed to be from the GLP-1 family of drugs - originally developed to treat diabetes, which is now often used as a weight loss product.

U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for diabetes and weight loss, according to a review of patient data published on Monday, the ...